Results 191 to 200 of about 3,098,750 (348)

The physician scientist, peer review, and creativity [PDF]

, 1999
Ramon M. Fusaro
openalex   +1 more source

How does linguistic knowledge contribute to short-term memory?:Contrasting effects of impaired semantic knowledge and executive control [PDF]

, 2012
Ehsan, Sheeba, Hoffman, Paul, Jefferies, E., Jones, Roy W, Lambon Ralph, Matthew A   +4 more
core   +1 more source

Peer Review of Peer Review?

Science, 1990
openaire   +4 more sources

Single‐cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology

Molecular Oncology, EarlyView.
Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban, Shivakumar Keerthikumar, Ashlee Clark, Hong Wang, Belinda Phipson, Andrew Bakshi, Andrew Ryan, Heather Thorne, Renea A. Taylor, Mitchell G. Lawrence, Gail P. Risbridger, Roxanne Toivanen, David L. Goode   +12 more
wiley   +1 more source

Artificial Intelligence in Peer Review: Ethical Risks and Practical Limits. [PDF]

Turk Arch Otorhinolaryngol
Kemal Ö.
europepmc   +1 more source

Evidence on peer review---scientific quality control or smokescreen? [PDF]

, 1999
Sandy Goldbeck-Wood
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Human Expertise in an AI-Collaborative Peer-Review Process. [PDF]

Oncol Nurs Forum
Overcash J.
europepmc   +1 more source

Peer–review court battle averted [PDF]

, 1996
Fintan R. Steele
openalex   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source